ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 38 filers reported holding ESSA PHARMA INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510 | -56.1% | 165 | -61.6% | 0.00% | – |
| Q2 2023 | $1,162 | -88.0% | 430 | -86.8% | 0.00% | – |
| Q1 2023 | $9,664 | -41.2% | 3,254 | -50.1% | 0.00% | – |
| Q4 2022 | $16,435 | -81.7% | 6,522 | -77.2% | 0.00% | – |
| Q2 2022 | $90,000 | -53.6% | 28,551 | -9.2% | 0.00% | – |
| Q1 2022 | $194,000 | -56.1% | 31,442 | +1.1% | 0.00% | – |
| Q4 2021 | $442,000 | +271.4% | 31,113 | +109.0% | 0.00% | – |
| Q3 2021 | $119,000 | -92.8% | 14,886 | -74.4% | 0.00% | -100.0% |
| Q2 2021 | $1,658,000 | +6532.0% | 58,040 | +6586.6% | 0.00% | – |
| Q1 2021 | $25,000 | +400.0% | 868 | +114.9% | 0.00% | – |
| Q4 2020 | $5,000 | -73.7% | 404 | -85.3% | 0.00% | – |
| Q3 2020 | $19,000 | +171.4% | 2,751 | +69.3% | 0.00% | – |
| Q1 2020 | $7,000 | +75.0% | 1,625 | +128.2% | 0.00% | – |
| Q4 2019 | $4,000 | – | 712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 2,070,052 | $60,135,000 | 10.84% |
| Burrage Capital Management LLC | 237,442 | $6,898,000 | 5.59% |
| Asymmetry Capital Management, L.P. | 284,459 | $8,264,000 | 4.28% |
| BVF INC/IL | 2,908,326 | $84,487,000 | 3.17% |
| Stenahm Asset Managment Ltd | 147,113 | $4,274,000 | 3.01% |
| ACUTA CAPITAL PARTNERS, LLC | 287,000 | $8,337,000 | 3.01% |
| Avidity Partners Management LP | 2,840,000 | $82,502,000 | 2.28% |
| Vivo Capital, LLC | 2,068,907 | $60,102,000 | 2.11% |
| COMMODORE CAPITAL LP | 176,821 | $5,137,000 | 2.05% |
| Ally Bridge Group (NY) LLC | 363,185 | $10,551,000 | 2.02% |